TrademarkDir
ENTERICA
DEAD

Serial Number

88641366

Owner

CYTOSORBENTS CORPORATION

Attorney

Kevin M. Bovard

Filing Date

Oct 3, 2019

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

ENTERICA Trademark

Serial Number: 88641366

ENTERICA is a trademark filed by CYTOSORBENTS CORPORATION on October 3, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

CYTOSORBENTS CORPORATION (35 trademarks)

Suite K
Monmouth Junction, NJ 08852

Entity Type: 03

Trademark Details

Filing Date

October 3, 2019

Registration Date

Not Registered

Published for Opposition

September 1, 2020

Goods & Services

Therapeutic agent, namely, chemicals in the nature of internally administered therapeutic sorbent in the nature of synthetic, polymeric, or processed natural materials for pharmaceutical purposes designed to reduce cytokines, toxins, bile acids, and other inflammatory mediators intraluminally to reduce both local and systemic inflammation and tissue injury

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Nov 27, 2023 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Nov 27, 2023 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 13, 2023 EXRA
SOU EXTENSION 5 GRANTED
Apr 12, 2023 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 8, 2023 AITU
SOU EXTENSION 5 FILED
Mar 30, 2023 EXT5
SOU TEAS EXTENSION RECEIVED
Mar 30, 2023 EEXT
ASSIGNED TO EXAMINER
Feb 3, 2023 DOCK
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 28, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 28, 2022 TCCA
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 28, 2022 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 5, 2022 EXRA
SOU EXTENSION 4 GRANTED
Oct 3, 2022 EX4G
SOU EXTENSION 4 FILED
Oct 3, 2022 EXT4
SOU TEAS EXTENSION RECEIVED
Oct 3, 2022 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 6, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 6, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 6, 2022 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 23, 2022 EXRA
SOU EXTENSION 3 GRANTED
Apr 21, 2022 EX3G
SOU EXTENSION 3 FILED
Apr 21, 2022 EXT3
SOU TEAS EXTENSION RECEIVED
Apr 21, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 29, 2021 EXRA
SOU EXTENSION 2 GRANTED
Oct 27, 2021 EX2G
SOU EXTENSION 2 FILED
Oct 27, 2021 EXT2
SOU TEAS EXTENSION RECEIVED
Oct 27, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 29, 2021 EXRA
SOU EXTENSION 1 GRANTED
Apr 27, 2021 EX1G
SOU EXTENSION 1 FILED
Apr 27, 2021 EXT1
SOU TEAS EXTENSION RECEIVED
Apr 27, 2021 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 27, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 1, 2020 NPUB
PUBLISHED FOR OPPOSITION
Sep 1, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 12, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 29, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 30, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 30, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 30, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 20, 2020 GNRN
NON-FINAL ACTION E-MAILED
Jan 20, 2020 GNRT
NON-FINAL ACTION WRITTEN
Jan 20, 2020 CNRT
ASSIGNED TO EXAMINER
Jan 8, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 8, 2019 NWOS
NEW APPLICATION ENTERED
Oct 7, 2019 NWAP

Related Trademarks

More from this Owner

CYTOSORB THERAPEUTIC ECMO

CYTOSORB THERAPEUTIC ECMO

CYTOSORB THERAPEUTIC ECMO

CYTOSORB THERAPEUTIC ECMO

PURIFI

PURIFI

PURIFI

PURIFI

ENTERICA

ENTERICA

HEMODEFEND

HEMODEFEND